GLYCOPYRROLATE
GLYCOPYRROLATE · VAGAL REFLEX BRADYCARDIA ·+2
SOLCO-NOVAPLUS
Drug class
Glycopyrrolate
Glycopyrrolate is a specific active pharmaceutical ingredient rather than an autonomous therapeutic drug class; pharmacologically, it belongs to the synthetic anticholinergic or antimuscarinic class of quaternary ammonium compounds. Read more about Glycopyrrolate
62 drugs in this class 56 manufacturers
Drugs in Glycopyrrolate
GLYCOPYRROLATE
GLYCOPYRROLATE · SIALORRHEA
PAR HEALTH USA,
GLYCOPYRROLATE
GLYCOPYRROLATE · VAGAL REFLEX BRADYCARDIA ·+2
XIROMED, LLC
GLYCOPYRROLATE
GLYCOPYRROLATE · VAGAL REFLEX BRADYCARDIA ·+2
XIROMED-NOVAPLU
GLYCOPYRROLATE
GLYCOPYRROLATE
Avet Pharmaceuticals
GLYCOPYRROLATE
GLYCOPYRROLATE · VAGAL REFLEX BRADYCARDIA ·+2
MEITHEAL-HEALTH
GLYCOPYRROLATE
GLYCOPYRROLATE · SIALORRHEA
TARO/SUN PHARMA
GLYCOPYRROLATE
GLYCOPYRROLATE · SIALORRHEA
PRECISION DOSE
GLYCOPYRROLATE
GLYCOPYRROLATE
QUAGEN PHARMACE
Filter & compare in the drug finder →
Opens the drug finder with Glycopyrrolate preselected. Add indication or manufacturer filters there.
Glycopyrrolate is a specific active pharmaceutical ingredient rather than an autonomous therapeutic drug class; pharmacologically, it belongs to the synthetic anticholinergic or antimuscarinic class of quaternary ammonium compounds.
It acts by competitively antagonizing acetylcholine at peripheral muscarinic receptors, thereby inhibiting parasympathetic nerve impulses and reducing secretions from exocrine glands and mucosal tissues while relaxing smooth muscle.
Clinically, it is used in anesthesia to reduce salivation, bronchial secretions, and vagal cardiac reflexes, as adjunctive therapy for peptic ulcer disease, and in various formulations to treat chronic obstructive pulmonary disease, severe drooling associated with neurologic conditions, and primary axillary hyperhidrosis.
-
fda.gov
Glycopyrrolate is a specific active pharmaceutical ingredient rather than an autonomous therapeutic drug class; pharmacologically, it belongs to the synthetic anticholinergic or antimuscarinic class of quaternary ammonium compounds It acts by competitively antagonizing acetylcholine at peripheral muscarinic receptors, thereby inhibiting parasympathetic nerve impulses and reducing secretions from exocrine glands and mucosal tissues while relaxing smooth muscle
-
fda.gov
Glycopyrrolate is a specific active pharmaceutical ingredient rather than an autonomous therapeutic drug class; pharmacologically, it belongs to the synthetic anticholinergic or antimuscarinic class of quaternary ammonium compounds It acts by competitively antagonizing acetylcholine at peripheral muscarinic receptors, thereby inhibiting parasympathetic nerve impulses and reducing secretions from exocrine glands and mucosal tissues while relaxing smooth muscle
-
fda.gov
Clinically, it is used in anesthesia to reduce salivation, bronchial secretions, and vagal cardiac reflexes, as adjunctive therapy for peptic ulcer disease, and in various formulations to treat chronic obstructive pulmonary disease, severe drooling associated with neurologic conditions, and primary axillary hyperhidrosis
-
fda.gov
Clinically, it is used in anesthesia to reduce salivation, bronchial secretions, and vagal cardiac reflexes, as adjunctive therapy for peptic ulcer disease, and in various formulations to treat chronic obstructive pulmonary disease, severe drooling associated with neurologic conditions, and primary axillary hyperhidrosis
-
fda.gov
Clinically, it is used in anesthesia to reduce salivation, bronchial secretions, and vagal cardiac reflexes, as adjunctive therapy for peptic ulcer disease, and in various formulations to treat chronic obstructive pulmonary disease, severe drooling associated with neurologic conditions, and primary axillary hyperhidrosis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.